FDA Warns Against Imported Dietary Supplements
Consumers, beware! Imported products marketed as "dietary supplements" or "herbal alternatives" to prescription drugs may do you more harm than good.
An Added Benefit of HIV Therapy
Hepatitis B infection can be a serious risk for patients with HIV. But there may be some good news on that front.
Global HIV Efforts Ramped Up
In its effort to put a stop to the AIDS epidemic by 2030, the World Health Organization (WHO) has made some big changes to its guidelines for global HIV treatment.
Preventing HIV with a Pill
A single pill could soon become an important tool in the fight against HIV.
Hep C Type 3 Treatment Approved
The U.S. Food and Drug Administration today approved Daklinza (daclatasvir) for use with sofosbuvir to treat hepatitis C virus (HCV) genotype 3 infections.
FDA Approves Novel Hep C Rx
The U.S. Food and Drug Administration today approved Technivie (ombitasvir, paritaprevir and ritonavir) for use in combination with ribavirin for the treatment of hepatitis C virus (HCV) genotype 4 infections in patients without scarring and poor liver function (cirrhosis).
Hep C Estimates Could Be Way Off
Knowing how common a certain condition is can help prepare health care systems to treat patients. But the estimates for one disease may be way off.
Some Patients Might Not Know They Have HIV
Patients with HIV are now able to live longer and healthier lives than ever before — but only when their HIV status is known and treated.
HPV Vaccine: How Many Doses Does It Really Take?
Doctors don't usually encourage patients to deviate from their vaccination schedules, but new evidence suggests that less may actually be more — at least when it comes to the HPV vaccine.
Why Early HIV Treatment Matters
There may be some good news for HIV patients — starting medication immediately after diagnosis may help keep patients healthy longer.